|
|
Article: Biocompatibles International plc - Statement re regulatory application in China.
- Article from:
- PR Newswire UK Disclose
- Article date:
- August 7, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
7 August 2009
BIOCOMPATIBLES INTERNATIONAL PLC
("Biocompatibles" or the "Company")
Update on status of DC Beadao regulatory application in China
Farnham UK, 7 August 2009: Biocompatibles International plc (LSE:BII) refers to
the following statement made on 4 August 2009 by SciClone Pharmaceuticals, Inc.
(Nasdaq:SCLN), the Company's distribution partner for China. Within the report
of its second quarter 2009 results, SciClone stated:
"SciClone has recently learned from SFDA regarding its regulatory application
of DC Beadao, a product for the treatment of liver cancer, that in order for the
agency to complete ...